Status: current, Defined. Date: 31-Mar 2021. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4539591000168116 | A/Hong Kong/2671/2019 (H3N2)-like virus cell based + A/Wisconsin/588/2019 (H1N1)pdm09-like virus cell based + B/Phuket/3073/2013-like virus cell based + B/Washington/02/2019-like virus cell based (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4539601000168111 | influenza quadrivalent cell based vaccine 2021 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
influenza quadrivalent cell based vaccine 2021 | Is a | medicinal product | true | Inferred relationship | Some | ||
influenza quadrivalent cell based vaccine 2021 | has intended active ingredient | A/Wisconsin/588/2019 (H1N1)pdm09-like virus cell based | true | Inferred relationship | Some | 1936790298 | |
influenza quadrivalent cell based vaccine 2021 | has intended active ingredient | B/Washington/02/2019-like virus cell based | true | Inferred relationship | Some | 316998590 | |
influenza quadrivalent cell based vaccine 2021 | has intended active ingredient | A/Hong Kong/2671/2019 (H3N2)-like virus cell based | true | Inferred relationship | Some | 1479952771 | |
influenza quadrivalent cell based vaccine 2021 | has intended active ingredient | B/Phuket/3073/2013-like virus cell based | true | Inferred relationship | Some | 2113949956 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
influenza quadrivalent cell based vaccine 2021, 0.5 mL syringe | Is a | True | influenza quadrivalent cell based vaccine 2021 | Inferred relationship | Some |
Reference Sets
Medicinal product reference set